rs863225023
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001540.5(HSPB1):c.523C>T(p.Gln175*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000131 in 152,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001540.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248140Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134702
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461490Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727038
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not provided Pathogenic:2
A variant that is likely pathogenic has been identified in the HSPB1 gene. The Q175X nonsense variant has been previously reported to segregate with CMT2 in six affected family members (Rossor et al., 2012). This variant is predicted to cause loss of normal protein function through protein truncation as the last 31 amino acid residues are lost. The Q175X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). Therefore, the Q175X variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
This variant creates a premature stop codon resulting in a truncated HSPB1. Similar truncating variants in this gene have been reported in cases of axonal Charcot-Marie-Tooth disease (PMID: 32334137, 26675522). The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in multiple unrelated individuals with motor neuropathies and appears to segregate with axonal Charcot-Marie-Tooth disease in at least one family. -
Charcot-Marie-Tooth disease axonal type 2F Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln175*) in the HSPB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 31 amino acid(s) of the HSPB1 protein. This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with autosomal dominant Charcot-Marie-Tooth disease (PMID: 22734906, 28144995). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 217231). This variant is located in a region of the HSPB1 protein where a significant number of HSPB1 nonsense and frameshift mutations have been reported in association with autosomal dominant HSPB1-related neuropathies (PMID: 22734906, 28144995, 33686258). For these reasons, this variant has been classified as Pathogenic. -
Charcot-Marie-Tooth disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at